Related Experiment Video
Updated: Jan 17, 2026

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
Published on: December 15, 2017
Orally ROS/pH Dual-Responsive and Targeted Fucoxanthin Microspheres for the Alleviation of Colon Inflammation
Shuifang Mao1,2, Yanming Ren1, Wen Tan1
1College of Biosystems Engineering and Food Science, Zhejiang Key Laboratory of Agri-Food Resources and High-Value Utilization, Zhejiang Engineering Laboratory of Food Technology and Equipment, Zhejiang University, Hangzhou, 310058, China.
Abstract:
Inspired by the excellent antioxidant and anti-inflammatory effects of fucoxanthin and polyphenols, a pH/ROS dual-response, dual targeting, and gastric stability fucoxanthin microspheres (SA@CCT@MPN@FX) for the effective mitigation of ulcerative colitis (UC) are developed in present study. Metal-phenolic nanoparticles formed from epigallocatechin gallate (EGCG) and Fe3+ are employed as the carrier to encapsulate fucoxanthin, followed by surface coating with chondroitin sulfate modified (5-carboxypentyl) (triphenyl) phosphonium bromide, and finally coated with sodium alginate. Structural characterization confirms the successful encapsulation of fucoxanthin within uniformly dispersed core-shell nanostructures. The dual-responsive release characteristics of fucoxanthin in the targeted nanoparticles are observed at low pH and in the presence of 10 × 10-3 m hydrogen peroxide (H2O2) at pH7.4. Meanwhile, the fabricated fucoxanthin targeted nanoparticles shows excellent macrophage and mitochondrial targeting abilities, the SA@CCT@MPN@FX microspheres can substantially alleviate UC by downregulating the expression levels of oxidative stress and inflammatory cytokines, repairing intestinal damage, ameliorating the composition and relative abundance of intestinal microbiota and short-chain fatty acids levels through the synergistic antioxidant effects of fucoxanthin and EGCG. This study provides a streamlined strategy for constructing dual-responsive targeted delivery systems as well as highlights the potential of oral hydrophobic bioactive substances for UC intervention.
More Related Videos
04:53Detection of Total Reactive Oxygen Species in Adherent Cells by 2',7'-Dichlorodihydrofluorescein Diacetate Staining
Published on: June 23, 2020
07:04Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...